Towards Continuous Manufacturing – what are the challenges key industry players are facing when trying to establish continuous manufacturing processes in biologics? Join this panel to find out what role technology, equipment and regulations play in the implementation of continuous manufacturing processes.
As the biologics industry grows, biopharmaceutical companies are looking for ways to increase efficiency and speed to market for their biologic drugs. One area of focus is drug substance development and biomanufacturing. During this interview, Andrew Sandford, VP, Business Development - Biologics at Catalent Biologics, will discuss emerging trends and technologies and how they will impact biomanufacturing in the future